Cyclophosphamide vs rituximab induction therapy for ANCA-associated vasculitis. A systematic review and meta-analysis of 12-month mortality. // Seminars in Arthritis and Rheumatism. – URL: https://www.sciencedirect.com/science/article/pii/S004901722600168X?dgcid=rss_sd_all
Cyclophosphamide vs rituximab induction therapy for ANCA-associated vasculitis. A systematic review and meta-analysis of 12-month mortality. Seminars in Arthritis and Rheumatism. https://www.sciencedirect.com/science/article/pii/S004901722600168X?dgcid=rss_sd_all
“Cyclophosphamide vs rituximab induction therapy for ANCA-associated vasculitis. A systematic review and meta-analysis of 12-month mortality.” Seminars in Arthritis and Rheumatism.
@article{article65650,
title = {Cyclophosphamide vs rituximab induction therapy for ANCA-associated vasculitis. A systematic review and meta-analysis of 12-month mortality},
journal = {Seminars in Arthritis and Rheumatism},
url = {https://www.sciencedirect.com/science/article/pii/S004901722600168X?dgcid=rss_sd_all}
}